Novartis strikes a $1.9B partnership with Antares Therapeutics to tackle “undruggable” cancer targets.
Novartis has entered into a strategic collaboration and license agreement with Antares Therapeutics to discover and develop next-generation small molecule oncology treatments. The transaction...
Trodelvy Approved in Europe for Hard-to-Treat Breast Cancer Patients
The European Commission has granted marketing authorization for Trodelvy® (sacituzumabgovitecan) as an initial treatment for adults with unresectable or metastatic triple-negative breast cancer (mTNBC) who are ineligible...
Novaspire Biosciences and Abhinavayan Biotech Announce Strategic Leadership and Core Partnership
Novaspire Biosciences, a premier clinical research organization, announced a strategic evolution in its leadership and ownership structure through a core partnership with Abhinavayan Biotech. This collaboration marks...
FDA Reaches Out to Indian Pharma Amid Critical Ifosfamide Shortage in U.S.
A chemotherapy drug that stands between cancer patients and their treatment has gone dangerously scarce in the United States, compelling federal health regulators to...
Maiva Pharma launches brand-new, 22-acre sterile injectables plant in Tamil Nadu
Maiva Pharma Private Limited, a leading US FDA-approved sterile injectables manufacturer, has officially inaugurated its brand-new manufacturing plant. Spanning a sprawling 22-acre campus in Shoolagiri, Tamil Nadu, the...
EU approved Sanofi’s Cenrifki as first disability-taegeting medicine for SPMS
Sanofi announced that the European Commission has approved Cenrifki (tolebrutinib), marking a historic milestone as the first and only therapy authorized in the European Union specifically...